✦ LIBER ✦

IMMUNOTHERAPY OF HUMAN MALIGNANT MELANOMA WITH IRRADIATED TUMOR CELLS, ORAL BACILLUS CALMETTE-GUÉRIN, AND LEVAMISOLE

✍ Scribed by Henry R. Shibata; L. Martin Jerry; Martin G. Lewis; Peter W. A. Mansell; Alena Capek; Grace Marquis

Book ID: 114882476
Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 631 KB
Volume: 277
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1976.tb41714.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IMMUNOTHERAPY OF HUMAN SOLID TUMORS WITH

IMMUNOTHERAPY OF HUMAN SOLID TUMORS WITH BACILLUS CALMETTE-GUÉRIN: PROLONGATION OF DISEASE-FREE INTERVAL AND SURVIVAL IN MALIGNANT MELANOMA, BREAST, AND COLORECTAL CANCER

✍ Jordan U. Gutterman; Giora M. Mavligit; George Blumenshein; Michael A. Burgess; 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 937 KB

Active Specific Immunotherapy of Human C

Active Specific Immunotherapy of Human Colorectal Carcinoma with an Autologous Tumor Cell/Bacillus Calmette-Guérin Vaccine

✍ MICHAEL G. HANNA Jr.; JANET H. RANSOM; NICHOLAS POMATO; LEONA PETERS; ELISABETH 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

IMMUNOTHERAPY OF CANCER WITH CELL WALL S

IMMUNOTHERAPY OF CANCER WITH CELL WALL SKELETON OF MYCOBACTERIUM BOVIS-BACILLUS CALMETTE-GUÉRIN: EXPERIMENTAL AND CLINICAL RESULTS

✍ Yuichi Yamamura; Ichiro Azuma; Tadayoshi Taniyama; Kazuhisa Sugimura; Fumio Hira 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 943 KB

Bacillus Calmette-Guerin immunotherapy o

Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells

✍ Rafael Carretero; Teresa Cabrera; Hernani Gil; Pablo Saenz-Lopez; Isabel Maleno; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 355 KB

Bacillus Calmette-Guerin (BCG) immunotherapy is a standard treatment for high-risk non-muscle-infiltrating bladder cancer patients. Although the outcomes are good, cancer relapse is observed in around 40% of patients. We present the comparative analysis of human leukocyte antigen (HLA) class I expre

Adjuvant immunotherapy treatment of rena

Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized study

✍ Enzo Galligioni; Michele Quaia; Alberto Merlo; Antonino Carbone; Antonella Spada 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

## BACKGROUND. Active specific immunotherapy (ASI) is a strategy that attempts to boost the host's immune response specifically against its own tumor. The purpose of this study was to investigate the effect of adjuvant AS1 in patients with renal carcinoma. ## METHODS. Of 120 consecutive patient